Data as of Aug 26
| +0.09 / +2.38%|
The 4 analysts offering 12-month price forecasts for Sequenom Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 3.20. The median estimate represents a +29.20% increase from the last price of 3.87.
The current consensus among 7 polled investment analysts is to Buy stock in Sequenom Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.